Observational studyBMC musculoskeletal disorders2026
Assessing lower-limb prosthetic users with the amputee mobility predictor with prosthesis and timed up and go tests.
Observational study in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLower-limb amputation (LLA) significantly impacts mobility, independence, and quality of life. Reliable assessment tools are essential for evaluating functional capacity, guiding prosthetic prescription, and identifying individuals at risk of falls. The Amputee Mobility Predictor with prosthesis (AMPPro) and Timed Up and Go (TUG) test are commonly used performance-based measures, yet their complementary utility in clinical practice among LLA populations in Jordan remains underexplored.
objectiveTo evaluate functional mobility among lower-limb prosthetic users using AMPPro and TUG, examine associations with demographic and clinical factors, and assess the predictive value of AMPPro for fall risk. STUDY
designCross-sectional observational study.
methodSixty-three adults with unilateral lower-limb amputation were assessed using AMPPro and TUG. Demographic and clinical data, including age, gender, amputation etiology, level, time since amputation, and time since first prosthetic fitting, were collected. Statistical analyses included Spearman correlations, non-parametric tests, and multivariable regression to examine associations and predictors of functional outcomes and fall risk.
resultsParticipants were predominantly male (71.4%) with a mean age of 43.7 ± 14.5 years. Median AMPPro score was 43/47, and median TUG time was 14 s, with 54% at risk of falls. AMPPro and TUG were strongly inversely correlated (ρ = - 0.603, p < 0.001). Age and amputation cause significantly influenced functional outcomes, while time since amputation, time since first fitting, and amputation level did not. Each one-point increase in AMPPro reduced fall risk by 17% (OR = 0.83, p = 0.004).
conclusionAMPPro and TUG provide complementary assessments of mobility in lower-limb prosthetic users. AMPPro effectively distinguishes functional levels and predicts fall risk, supporting its use alongside demographic and clinical data for individualized rehabilitation and fall-prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.